Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery ...
PODD's Omnipod 5 momentum and global growth support its outlook, but competitive pressure and macro costs may test its margin ...
Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation (“Insulet” or the “Company”) ...
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results